SCHEMBL4867939

SCHEMBL4867939

CCCCC(Br)C(=O)ON1C(=O)CCC1=O

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ZDHHC7 Q9NXF8 2/20 0.47
LCK P06239 1/20 0.40
PPARD Q03181 1/20 0.40
ZDHHC20 Q5W0Z9 1/20 0.40
ZDHHC2 Q9UIJ5 1/20 0.40
CA2 P00918 3/20 0.35
CA1 P00915 1/20 0.35
CYP3A4 P08684 3/20 0.35
TSHR P16473 3/20 0.35
ATM Q13315 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
ALDH1A1 P00352 4/20 0.34
LMNA P02545 2/20 0.33
HSD17B10 Q99714 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
KDM4E B2RXH2 1/20 0.33
FAAH O00519 1/20 0.33
MAPK1 P28482 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23802513 0.85 CA2 (0.43) CA2CA1CYP3A4TSHRATM
SCHEMBL10026333 0.84 CA1 (0.37) CA2CA1CYP3A4TSHRATM
SCHEMBL18540901 0.84 CA1 (0.37) CA2CA1CYP3A4TSHRATM
SCHEMBL4591173 0.83 DPP7 (0.38) CA2CA1KMT2ASMN1; SMN2KDM4E
SCHEMBL18540023 0.83 CA2 (0.53) CA2CA1ATMALDH1A1MAPK1
SCHEMBL9504953 0.83 DPP7 (0.38) CA2CA1KMT2ASMN1; SMN2KDM4E
SCHEMBL19820110 0.83 CA2 (0.41) CA2CA1CYP3A4TSHRTDP1
SCHEMBL19404107 0.83 CA2 (0.41) ZDHHC7CA2CA1ALDH1A1KMT2A
SCHEMBL92976 0.81 CA2 (0.37) CA2CA1CYP3A4TSHRATM
SCHEMBL20624810 0.81 CA2 (0.44) ZDHHC7CA2CA1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7371585-B2 Membranes incorporating recognition moieties GENENCOR INTERNATIONAL, INC. (US) 2008-05-13 US disclosed
EP-1699420-A1 MEMBRANES INCORPORATING RECOGNITION MOIETIES GENENCOR INTERNATIONAL, INC. (US) 2006-09-13 EP disclosed
US-20050250128-A1 Membranes incorporating recognition moieties GENENCOR INTERNATIONAL, INC. 2005-11-10 US disclosed
WO-2005065405-A1 MEMBRANES INCORPORATING RECOGNITION MOIETIES GENENCOR INTERNATIONAL, INC. (US) 2005-07-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050250128-A1 Membranes incorporating recognition moieties TMIGD3, GOLIM4, PTDSS2 ZDHHC7 1474/4885LCK 2495/4885PPARD 2571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.